Dr. Beverly Tchang shares a finding from the American College of Gastroenterology meeting: GLP-1 use was linked to a 67.5% lower colorectal cancer risk.
Recap by typeshit. Post by Beverly G. Tchang, MD on X.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
13:47
Ketcham runs through the habits she credits for her 90 pound loss on tirzepatide. Her personal take, not medical advice, so check with a doctor.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
Loading…